Education
About Us
Working with TipRanks
Follow Us
American Oncology Network, Inc. Class A (AONC)
:AONC
RESEARCH TOOLSreports
Total Valuation
American Oncology Network has a market cap or net worth of $271.32M. The enterprise value is ―.
Market Cap$271.32M
Enterprise Value―
Share Statistics
American Oncology Network has 32,088,710 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,088,710
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
American Oncology Network’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee668.33K
Profits Per Employee-32.99K
Employee Count1,914
Asset Turnover3.42
Inventory Turnover26.84
Valuation Ratios
The current PE Ratio of American Oncology Network is -7.12. American Oncology Network’s PEG ratio is -0.29.
PE Ratio-7.12
PS Ratio0.00
PB Ratio-1.57
Price to Fair Value-0.24
Price to FCF3.80
Price to Operating Cash Flow1.21
PEG Ratio-0.29
Income Statement
In the last 12 months, American Oncology Network had revenue of 1.28B and earned -5.54M in profits. Earnings per share was -1.36.
Revenue1.28B
Gross Profit82.80M
Operating Income-49.15M
Pretax Income-62.51M
Net Income-5.54M
EBITDA-39.35M
Earnings Per Share (EPS)-1.36
Cash Flow
In the last 12 months, operating cash flow was 5.10M and capital expenditures -13.34M, giving a free cash flow of -8.24M billion.
Operating Cash Flow5.10M
Free Cash Flow-8.24M
Free Cash Flow per Share-0.26
Dividends & Yields
American Oncology Network pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.16
52-Week Price Change188.73%
50-Day Moving Average5.69
200-Day Moving Average4.57
Relative Strength Index (RSI)50.09
Average Volume (3m)2.06K
Important Dates
American Oncology Network upcoming earnings date is Nov 18, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
American Oncology Network as a current ratio of 1.64, with Debt / Equity ratio of -369.98%
Current Ratio1.64
Quick Ratio1.38
Debt to Market Cap2.04
Net Debt to EBITDA―
Interest Coverage Ratio-7.66
Taxes
In the past 12 months, American Oncology Network has paid 384.00K in taxes.
Income Tax384.00K
Effective Tax Rate>-0.01
Enterprise Valuation
American Oncology Network EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
American Oncology Network has $19.43M in cash and marketable securities with $143.70M in debt, giving a net cash position of $124.27M billion.
Cash & Marketable Securities$19.43M
Total Debt$143.70M
Net Cash$124.27M
Net Cash Per Share$3.87
Tangible Book Value Per Share$10.39
Margins
Gross margin is 5.27%, with operating margin of -3.84%, and net profit margin of -0.43%.
Gross Margin5.27%
Operating Margin-3.84%
Pretax Margin-4.89%
Net Profit Margin-0.43%
EBITDA Margin-3.08%
EBIT Margin-4.38%
Analyst Forecast
The average price target for American Oncology Network is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast166.39%
EPS Growth Forecast15.50%